국가: 이집트
언어: 영어
출처: EDA (Egyptian Drug Authority)
Rafoxanide 22.5 mg + Levamisole hydrochloride 15 mg /1ml
Egyptian European CO
Oral Suspension
Chanelle Pharmaceuticals Manufacturing Ltd - Ireland